Results 1 to 10 of about 45,524 (288)

QUO VADIS PSYCHIATRIC TREATMENTS? Seventy Years of Modern Psychopharmacology and Thirty Years of “Psychiatry and Clinical Psychopharmacology”

Psychiatry and Clinical Psychopharmacology, 2021
To cite this article: Cetin M, Aricioglu F, Dursun S. QUO VADIS PSYCHIATRIC TREATMENTS? Seventy Years of Modern Psychopharmacology and Thirty Years of “Psychiatry and Clinical Psychopharmacology”.
Mesut Cetin, Feyza Aricioglu, Serdar Dursun   +2 more
doaj   +2 more sources

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

Pharmacy, 2021
Although clinical pharmacy is a discipline that emerged in the 1960s, the question of precisely how pharmacists can play a role in therapeutic optimization remains unanswered.
Hervé Javelot, Clara Gitahy Falcao Faria, Frederik Vandenberghe, Sophie Dizet, Bastien Langrée, Mathilde Le Maout, Céline Straczek, Adeline Egron, Alexis Erb, Guillaume Sujol, Antoine Yrondi, Sébastien Weibel, Philippe D. Vincent, Guillaume Meyer, Coraline Hingray   +14 more
doaj   +2 more sources

Anticholinergic Drugs in Geriatric Psychopharmacology [PDF]

Frontiers in Neuroscience, 2019
Drugs with anticholinergic action are widely prescribed in the elderly population due to their potential clinical benefits. However, these benefits are limited by adverse effects which may be serious in particular circumstances.
Jorge López‐Álvarez, Julia Sevilla‐Llewellyn‐Jones, Luis Agüera-Ortíz   +2 more
openalex   +2 more sources

Translational psychopharmacology [PDF]

Journal of Psychopharmacology, 2021
Allan H. Young
openalex   +4 more sources

Disruptive Psychopharmacology

JAMA Psychiatry, 2019
The paucity of medications with novel mechanisms for the treatment of mental illnesses combined with the delayed response to currently available medications has led to great excitement about the potential therapeutic utility of previously demonized drugs,
Boris D, Heifets, Robert C, Malenka
openaire   +4 more sources

Comprehensive Management of Severe Mental Disorders: The Synergy between Multifamily Groups and Psychopharmacology [PDF]

Eur Psychiatry
Albillos Pérez R, Castelao Almodóvar S, González Núñez R, Castelao Escobar A, Sanz Sánchez P, Alguacil Núñez C.   +5 more
europepmc   +3 more sources

Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology

Journal of Psychopharmacology, 2023
The British Association for Psychopharmacology developed an evidence-based consensus guideline on the management of catatonia. A group of international experts from a wide range of disciplines was assembled. Evidence was gathered from existing systematic
Jonathan P. Rogers, Mark A. Oldham, G. Fricchione, G. Northoff, Jo Ellen Wilson, S. Mann, A. Francis, A. Wieck, Lee Elizabeth Wachtel, G. Lewis, S. Grover, D. Hirjak, N. Ahuja, M. Zandi, A. Young, K. Fone, S. Andrews, D. Kessler, T. Saifee, S. Gee, D. Baldwin, Anthony S. David   +21 more
semanticscholar   +1 more source

Psychiatric nosological historiography - Part II: psychopharmacology and somatogenic perspectives

Debates em Psiquiatria, 2023
Introduction: The history of psychiatry encompasses the evolving concepts about the relationship between body and mind and also of the definiton of normality, which depend on the knowledge and customs of different times and places.
Marleide de Mota Gomes, Mauro Vitor Mendlowicz, Antonio Egidio Nardi   +2 more
doaj   +1 more source

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines

Journal of Psychopharmacology, 2015
Anthony J. Cleare, Carmine M. Pariante, Allan H. Young, Ian Anderson, David Christmas, Philip J. Cowen, Chris Dickens, I. Nicol Ferrier, John Geddes, Simon Gilbody, Peter Haddad, Cornelius Katona, Glyn Lewis, Andrea L. Malizia, R. Hamish McAllister‐Williams, Paul Ramchandani, Jan Scott, David Taylor, Rudolf Uher, the members of the Consensus Meeting   +19 more
openalex   +3 more sources

Impact of the Aversive Effects of Drugs on Their Use and Abuse

Behavioural Neurology, 2022
Drug use and abuse are complex issues in that the basis of each may involve different determinants and consequences, and the transition from one to the other may be equally multifaceted.
Anthony L. Riley, Hayley N. Manke, Shihui Huang   +2 more
doaj   +1 more source